Benjamin J Resio1, Lou Gonsalves2, Maureen Canavan3, Lloyd Mueller2, Cathryn Phillips2, Tejas Sathe4, Katrina Swett2, Daniel J Boffa5. 1. Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, USA. 2. Connecticut Tumor Registry, Hartford, CT, USA. 3. Department of Internal Medicine, Cancer Outcomes and Public Policy and Effectiveness Research (COPPER), Yale School of Medicine, New Haven, CT, USA. 4. Yale School of Medicine, New Haven, CT, USA. 5. Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, USA. daniel.boffa@yale.edu.
Abstract
BACKGROUND: Nearly half of operative mortalities occur outside the traditionally studied 30-day period after surgery. To identify additional opportunities to improve surgical safety, the circumstances of deaths occurring 31-90 days after complex cancer surgery are analyzed. PATIENTS AND METHODS: Patients aged ≥ 65 years who died within 90 days of complex cancer surgery for nonmetastatic cancer were analyzed in the Surveillance, Epidemiology, and End Results (SEER)-Medicare and the Connecticut Tumor Registry (CTR) databases. RESULTS: Of the 36,114 patients undergoing complex cancer surgery from 2004 to 2013 in SEER-Medicare, 1367 (3.8%) died within 31-90 days ("late mortalities"). Seventy-eight percent of late mortalities were readmitted prior to death. The highest proportion of late mortalities occurred during a readmission (49%), and 11% were never discharged from their index admission. Cause of death (COD) was largely attributed to the malignancy itself (56%), which is unlikely to be the underlying cause. Of the noncancer COD, cardiac causes were most frequent (34%), followed by pulmonary causes (18%). Death was rarely attributed to thromboembolic disease (< 1%). The CTR provided location of death, which was most commonly in a hospital (65%) or nursing facility (20%); death at home was rare (6%). CONCLUSIONS: The vast majority of patients dying between 31 and 90 days of surgery were admitted to a hospital or nursing facility at the time of their death after initially being discharged, and few patients died at home. Greater clarity in death documentation is needed to identify specific opportunities to rescue patients from fatal complications arising in the later postoperative period.
BACKGROUND: Nearly half of operative mortalities occur outside the traditionally studied 30-day period after surgery. To identify additional opportunities to improve surgical safety, the circumstances of deaths occurring 31-90 days after complex cancer surgery are analyzed. PATIENTS AND METHODS: Patients aged ≥ 65 years who died within 90 days of complex cancer surgery for nonmetastatic cancer were analyzed in the Surveillance, Epidemiology, and End Results (SEER)-Medicare and the Connecticut Tumor Registry (CTR) databases. RESULTS: Of the 36,114 patients undergoing complex cancer surgery from 2004 to 2013 in SEER-Medicare, 1367 (3.8%) died within 31-90 days ("late mortalities"). Seventy-eight percent of late mortalities were readmitted prior to death. The highest proportion of late mortalities occurred during a readmission (49%), and 11% were never discharged from their index admission. Cause of death (COD) was largely attributed to the malignancy itself (56%), which is unlikely to be the underlying cause. Of the noncancer COD, cardiac causes were most frequent (34%), followed by pulmonary causes (18%). Death was rarely attributed to thromboembolic disease (< 1%). The CTR provided location of death, which was most commonly in a hospital (65%) or nursing facility (20%); death at home was rare (6%). CONCLUSIONS: The vast majority of patients dying between 31 and 90 days of surgery were admitted to a hospital or nursing facility at the time of their death after initially being discharged, and few patients died at home. Greater clarity in death documentation is needed to identify specific opportunities to rescue patients from fatal complications arising in the later postoperative period.
Authors: Katherine S Rowell; Florence E Turrentine; Matthew M Hutter; Shukri F Khuri; William G Henderson Journal: J Am Coll Surg Date: 2007-06 Impact factor: 6.113
Authors: Deborah S Main; William G Henderson; Katherine Pratte; Tia A Cavender; Tracy L Schifftner; Anne Kinney; Tamara Stoner; John F Steiner; Aaron S Fink; Shukri F Khuri Journal: J Am Coll Surg Date: 2007-06 Impact factor: 6.113
Authors: Rupen Shah; Kristopher Attwood; Shipra Arya; Daniel E Hall; Jason M Johanning; Emmanuel Gabriel; Anthony Visioni; Steven Nurkin; Moshim Kukar; Steven Hochwald; Nader N Massarweh Journal: JAMA Surg Date: 2018-05-16 Impact factor: 14.766
Authors: Yoshihiro Mise; Jean-Nicolas Vauthey; Giuseppe Zimmitti; Nathan H Parker; Claudius Conrad; Thomas A Aloia; Jeffrey E Lee; Jason B Fleming; Matthew Harold G Katz Journal: Ann Surg Date: 2015-12 Impact factor: 12.969
Authors: David Yu Greenblatt; Kaitlyn J Kelly; Victoria Rajamanickam; Yin Wan; Todd Hanson; Robert Rettammel; Emily R Winslow; Clifford S Cho; Sharon M Weber Journal: Ann Surg Oncol Date: 2011-02-20 Impact factor: 5.344
Authors: Ryan P Merkow; Karl Y Bilimoria; Martin D McCarter; Mark E Cohen; Carlton C Barnett; Mehul V Raval; Joseph A Caprini; Howard S Gordon; Clifford Y Ko; David J Bentrem Journal: Ann Surg Date: 2011-07 Impact factor: 12.969
Authors: Robert A Hiatt; Caroline G Tai; Douglas W Blayney; Dennis Deapen; Michael Hogarth; Kenneth W Kizer; Joseph Lipscomb; Jennifer Malin; Stephen K Phillips; John Santa; Deborah Schrag Journal: J Natl Cancer Inst Date: 2015-03-11 Impact factor: 13.506
Authors: Darrell A Campbell; William G Henderson; Michael J Englesbe; Bruce L Hall; Michael O'Reilly; Dale Bratzler; E Patchen Dellinger; Leigh Neumayer; Barbara L Bass; Matthew M Hutter; James Schwartz; Clifford Ko; Kamal Itani; Steven M Steinberg; Allan Siperstein; Robert G Sawyer; Douglas J Turner; Shukri F Khuri Journal: J Am Coll Surg Date: 2008-10-10 Impact factor: 6.113
Authors: Justin B Dimick; Steven L Chen; Paul A Taheri; William G Henderson; Shukri F Khuri; Darrell A Campbell Journal: J Am Coll Surg Date: 2004-10 Impact factor: 6.113
Authors: Brent K Hollenbeck; David C Miller; David Taub; Rodney L Dunn; Shukri F Khuri; William G Henderson; James E Montie; Willie Underwood; John T Wei Journal: Cancer Date: 2006-04-01 Impact factor: 6.860